BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34409049)

  • 1. Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.
    Monzani D; Petrocchi S; Oliveri S; Veldwijk J; Janssens R; Bailo L; Smith MY; Smith I; Schoefs E; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Katz EG; Petrella F; Casiraghi M; Durosini I; Galli G; Garassino MC; de Wit GA; Pravettoni G; Huys I
    Front Med (Lausanne); 2021; 8():689114. PubMed ID: 34409049
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
    Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
    Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
    Oliveri S; Lanzoni L; Veldwijk J; de Wit GA; Petrocchi S; Janssens R; Schoefs E; Smith MY; Smith I; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Petrella F; Casiraghi M; Galli G; Garassino MC; Girvalaki C; Huys I; Pravettoni G
    Front Psychol; 2023; 14():1062830. PubMed ID: 37425173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients.
    Durosini I; Janssens R; Arnou R; Veldwijk J; Smith MY; Monzani D; Smith I; Galli G; Garassino M; Katz EG; Bailo L; Louis E; Vandevelde M; Nackaerts K; de Wit GA; Pravettoni G; Huys I
    Front Public Health; 2021; 9():622154. PubMed ID: 33634069
    [No Abstract]   [Full Text] [Related]  

  • 5. MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment.
    Tervonen T; Gelhorn H; Sri Bhashyam S; Poon JL; Gries KS; Rentz A; Marsh K
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1483-1491. PubMed ID: 28696023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project.
    Jimenez-Moreno AC; Pinto CA; Levitan B; Whichello C; Dyer C; Van Overbeeke E; de Bekker-Grob E; Smith I; Huys I; Viberg Johansson J; Adcock K; Bullock K; Soekhai V; Yuan Z; Lochmuller H; de Wit A; Gorman GS
    Wellcome Open Res; 2020; 5():253. PubMed ID: 34395923
    [No Abstract]   [Full Text] [Related]  

  • 7. What matters most to patients with multiple myeloma? A Pan-European patient preference study.
    Janssens R; Lang T; Vallejo A; Galinsky J; Morgan K; Plate A; De Ronne C; Verschueren M; Schoefs E; Vanhellemont A; Delforge M; Schjesvold F; Cabezudo E; Vandebroek M; Stevens H; Simoens S; Huys I
    Front Oncol; 2022; 12():1027353. PubMed ID: 36523996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences.
    Petrocchi S; Janssens R; Oliveri S; Arnou R; Durosini I; Guiddi P; Louis E; Vandevelde M; Nackaerts K; Smith MY; Galli G; de Marinis F; Gianoncelli L; Pravettoni G; Huys I
    Front Pharmacol; 2021; 12():602112. PubMed ID: 33746750
    [No Abstract]   [Full Text] [Related]  

  • 9. Discrete choice experiment versus swing-weighting: A head-to-head comparison of diabetic patient preferences for glucose-monitoring devices.
    Whichello C; Smith I; Veldwijk J; de Wit GA; Rutten-van Molken MPMH; de Bekker-Grob EW
    PLoS One; 2023; 18(7):e0283926. PubMed ID: 37506078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 11. Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment.
    Meirelles I; Magliano C
    Patient Prefer Adherence; 2021; 15():911-917. PubMed ID: 33958859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does being exposed to an educational tool influence patient preferences? The influence of an educational tool on patient preferences assessed by a discrete choice experiment.
    Bywall KS; Veldwijk J; Hansson MG; Baecklund E; Raza K; Falahee M; Kihlbom U
    Patient Educ Couns; 2021 Oct; 104(10):2577-2585. PubMed ID: 33757643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
    Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
    Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating patients' preferences for multiple myeloma therapy, a Discrete-Choice-Experiment.
    Mühlbacher AC; Lincke HJ; Nübling M
    Psychosoc Med; 2008 Dec; 5():Doc10. PubMed ID: 19742282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Patient Preferences in Rare Diseases: Direct Preference Elicitation in the Rare Chronic Kidney Disease, Immunoglobulin A Nephropathy.
    Marsh K; Ho KA; Lo R; Zaour N; George AT; Cook NS
    Patient; 2021 Nov; 14(6):837-847. PubMed ID: 34008165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.
    Sun H; Wang H; Shi L; Wang M; Li J; Shi J; Ni M; Hu X; Chen Y
    BMJ Open; 2020 Feb; 10(2):e032336. PubMed ID: 32051302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences for Sun Protection With a Self-Monitoring App: Protocol of a Discrete Choice Experiment Study.
    Nittas V; Mütsch M; Puhan MA
    JMIR Res Protoc; 2020 Feb; 9(2):e16087. PubMed ID: 32130187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
    de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
    Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and Public Acceptance of Digital Technologies in Health Care: Protocol for a Discrete Choice Experiment.
    Fischer AK; Mühlbacher AC
    JMIR Res Protoc; 2023 Aug; 12():e46056. PubMed ID: 37561559
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.